---
document_datetime: 2025-11-06 11:48:03
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/increlex-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: increlex-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 3.0719316
conversion_datetime: 2025-12-31 02:38:35.583549
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Increlex

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific informationafterauthorisation(archive).

| Applicationnumber   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|---------------------|----------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Article 61(3) /     | Notification acc.Article61(3)-Accepted | 06/11/2025                          |                                          | PL                              |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/N/0000307082                                        | Update of the package leaflet with revised contact details oflocal representatives.                                    |            |            |                        |
|---------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| Marketing Authorisation Transfer - H / EMA/T/0000281780 | -Transfer of a marketing authorisation- transferofmarketing authorisationfrom IpsenPharma toEstevePharmaceuticals S.A. | 16/07/2025 | 04/08/2025 | SmPC, Labelling and PL |